Tapewire

Nasdaq · USD

TLPH

TALPHERA, INC.

Export transactions ↓
Tapewire entity
7102
SEC CIK
0001427925
Parsed reports
249

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202640
Mar 202610
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 22, 2026 Filed Jun 24, 2026 21:09 UTC GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001853794-26-000002 · form4-06242026_090659.xml · derivative · entry 2

Bozilenko Marina · CIK 0001853794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:09 UTC GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001853794-26-000002 · form4-06242026_090659.xml · nonDerivative · entry 1

Bozilenko Marina · CIK 0001853794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,147

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:13 UTC
JAIN ABHINAVDirector
GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001981291-26-000002 · form4-06242026_090644.xml · derivative · entry 2

JAIN ABHINAV · CIK 0001981291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:13 UTC
JAIN ABHINAVDirector
GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001981291-26-000002 · form4-06242026_090644.xml · nonDerivative · entry 1

JAIN ABHINAV · CIK 0001981291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,412

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:15 UTC
WAN MARK ADirector
GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001190472-26-000002 · form4-06242026_090649.xml · derivative · entry 2

WAN MARK A · CIK 0001190472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:15 UTC
WAN MARK ADirector
GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001190472-26-000002 · form4-06242026_090649.xml · nonDerivative · entry 1

WAN MARK A · CIK 0001190472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,959

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:14 UTC GrantDirector Stock Option (right to buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001774807-26-000005 · form4-06242026_090645.xml · derivative · entry 2

Todisco Joseph · CIK 0001774807 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:14 UTC GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001774807-26-000005 · form4-06242026_090645.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,497

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:12 UTC GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001190418-26-000002 · form4-06242026_090614.xml · derivative · entry 2

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:12 UTC GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001190418-26-000002 · form4-06242026_090614.xml · nonDerivative · entry 1

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,959

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:10 UTC GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001305178-26-000002 · form4-06242026_090654.xml · derivative · entry 2

Broadfoot Jill Marie · CIK 0001305178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:10 UTC GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001305178-26-000002 · form4-06242026_090654.xml · nonDerivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,647

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:07 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to Buy) · Derivative 30,700 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001248144-26-000003 · form4-06242026_090645.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2036-06-21

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 21:07 UTC
ADAMS ADRIANDirector
GrantCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001248144-26-000003 · form4-06242026_090645.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,709

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
May 20, 2026 Filed May 21, 2026 21:01 UTC
Aslam ShakilChief Medical Officer
Tax withholdingCommon Stock 4,518 $0.82 $3,722.83
Disclosure

SEC source: 0002040805-26-000005 · form4-05212026_090524.xml · nonDerivative · entry 1

Aslam Shakil · CIK 0002040805 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,542

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 22:08 UTC
Aslam ShakilChief Medical Officer
Tax withholdingCommon Stock 2,118 $0.72 $1,529.83
Disclosure

SEC source: 0002040805-26-000003 · form4-04032026_100457.xml · nonDerivative · entry 1

Aslam Shakil · CIK 0002040805 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,060

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 22:10 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 9,938 $0.72 $7,178.22
Disclosure

SEC source: 0001700225-26-000004 · form4-04032026_100412.xml · nonDerivative · entry 1

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 790,767

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 22:09 UTC
ASADORIAN RAFFIChief Financial Officer
Tax withholdingCommon Stock 2,444 $0.72 $1,765.30
Disclosure

SEC source: 0001628970-26-000003 · form4-04032026_100414.xml · nonDerivative · entry 1

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,879

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 22:07 UTC
Dasu Badri NChief Engineering Officer
Tax withholdingCommon Stock 2,444 $0.72 $1,765.30
Disclosure

SEC source: 0001310803-26-000003 · form4-04032026_100455.xml · nonDerivative · entry 1

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,440

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
Nantahala Capital Management, LLC10% owner · See remarks
Harkey Wilmot B.10% owner · See remarks
Mack Daniel10% owner · See remarks
GrantPre-Funded Warrants · Derivative 4,266,211 $0.59 Strike: $0.00 $2,495,733.44
Disclosure

SEC source: 0001104659-26-029524 · tm269082-1_4seq1.xml · derivative · entry 1

Nantahala Capital Management, LLC · CIK 0001472322 · 10% owner · See remarks

Harkey Wilmot B. · CIK 0001775952 · 10% owner · See remarks

Mack Daniel · CIK 0001775831 · 10% owner · See remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 18,822,267

Underlying: Common Stock · 4,266,211 shares

Expires not disclosed

F1 · derivative.exercise_date: This Form 4 discloses the acquisition of pre-paid warrants to purchase shares of Talphera, Inc. common stock ("Common Stock"), which warrants are substantially similar to other warrants beneficially owned by the Reporting Persons; all such warrants are together referred to as the "Warrants." The Warrants are exercisable indefinitely.

F1 · derivative.expiration_date: This Form 4 discloses the acquisition of pre-paid warrants to purchase shares of Talphera, Inc. common stock ("Common Stock"), which warrants are substantially similar to other warrants beneficially owned by the Reporting Persons; all such warrants are together referred to as the "Warrants." The Warrants are exercisable indefinitely.

F2 · ownership.nature: NCM, an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold shares of Common Stock and certain derivative securities related thereto (the "Derivatives"), including Warrants, may be deemed a beneficial owner of such Warrants. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of the Warrants beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack (the "Reporting Persons") disclaims beneficial ownership of the Warrants disclosed herein except to the extent of their respective pecuniary interests therein.

Read SEC document
March 13, 2026 Filed Mar 25, 2026 23:57 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 213,310 $0.59 $124,999.66
Disclosure

SEC source: 0001700225-26-000003 · form4-03252026_110351.xml · nonDerivative · entry 1

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,705

F1 · shares: On March 31, 2025, Talphera (the "Issuer") entered into a securities purchase agreement with the Reporting Person and certain other institutional investors (the "PIPE"). The Reporting Person purchased shares in the closing of the third tranche of the PIPE conducted by the Issuer.

F2 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.

Read SEC document
February 14, 2026 Filed Feb 21, 2026 01:28 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 9,559 $0.79 $7,584.11
Disclosure

SEC source: 0001700225-26-000002 · form4-02212026_010244.xml · nonDerivative · entry 3

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 577,395

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
February 14, 2026 Filed Feb 21, 2026 01:25 UTC
Dasu Badri NChief Engineering Officer
Tax withholdingCommon Stock 2,346 $0.79 $1,861.32
Disclosure

SEC source: 0001310803-26-000002 · form4-02212026_010213.xml · nonDerivative · entry 3

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,884

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
February 14, 2026 Filed Feb 21, 2026 01:23 UTC
ASADORIAN RAFFIChief Financial Officer
Tax withholdingCommon Stock 2,933 $0.79 $2,327.04
Disclosure

SEC source: 0001628970-26-000002 · form4-02212026_010217.xml · nonDerivative · entry 3

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,323

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:27 UTC
Aslam ShakilChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 205,000 $0.00 Strike: $0.81 $0.00
Disclosure

SEC source: 0002040805-26-000002 · form4-02212026_010259.xml · derivative · entry 2

Aslam Shakil · CIK 0002040805 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 205,000 shares

Expires 2036-02-11

F2 · derivative.exercise_date: On February 12, 2026, the reporting person was granted an option to purchase 205,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:27 UTC
Aslam ShakilChief Medical Officer
PurchaseCommon Stock 35,000 $0.81 $28,430.50
Disclosure

SEC source: 0002040805-26-000002 · form4-02212026_010259.xml · nonDerivative · entry 1

Aslam Shakil · CIK 0002040805 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,178

F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:28 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 594,000 $0.00 Strike: $0.81 $0.00
Disclosure

SEC source: 0001700225-26-000002 · form4-02212026_010244.xml · derivative · entry 4

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 594,000

Underlying: Common Stock · 594,000 shares

Expires 2036-02-11

F4 · derivative.exercise_date: On February 12, 2026, the reporting person was granted an option to purchase 594,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:28 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 105,364 $0.81 $85,587.18
Disclosure

SEC source: 0001700225-26-000002 · form4-02212026_010244.xml · nonDerivative · entry 2

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 586,954

F3 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:25 UTC
Dasu Badri NChief Engineering Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $0.81 $0.00
Disclosure

SEC source: 0001310803-26-000002 · form4-02212026_010213.xml · derivative · entry 4

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2036-02-11

F3 · derivative.exercise_date: On February 12, 2026, the reporting person was granted an option to purchase 200,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:25 UTC
Dasu Badri NChief Engineering Officer
PurchaseCommon Stock 35,000 $0.81 $28,430.50
Disclosure

SEC source: 0001310803-26-000002 · form4-02212026_010213.xml · nonDerivative · entry 2

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,230

F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:23 UTC
ASADORIAN RAFFIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 260,000 $0.00 Strike: $0.81 $0.00
Disclosure

SEC source: 0001628970-26-000002 · form4-02212026_010217.xml · derivative · entry 4

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2036-02-11

F3 · derivative.exercise_date: On February 12, 2026, the reporting person was granted an option to purchase 260,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
February 12, 2026 Filed Feb 21, 2026 01:23 UTC
ASADORIAN RAFFIChief Financial Officer
PurchaseCommom Stock 45,000 $0.81 $36,553.50
Disclosure

SEC source: 0001628970-26-000002 · form4-02212026_010217.xml · nonDerivative · entry 2

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,256

F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029.

Read SEC document
February 10, 2026 Filed Feb 21, 2026 01:28 UTC
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 3,179 $0.84 $2,657.96
Disclosure

SEC source: 0001700225-26-000002 · form4-02212026_010244.xml · nonDerivative · entry 1

Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,590

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.

Read SEC document
February 10, 2026 Filed Feb 21, 2026 01:25 UTC
Dasu Badri NChief Engineering Officer
Tax withholdingCommon Stock 781 $0.84 $652.99
Disclosure

SEC source: 0001310803-26-000002 · form4-02212026_010213.xml · nonDerivative · entry 1

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,230

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
February 10, 2026 Filed Feb 21, 2026 01:23 UTC
ASADORIAN RAFFIChief Financial Officer
Tax withholdingCommon Stock 958 $0.84 $800.98
Disclosure

SEC source: 0001628970-26-000002 · form4-02212026_010217.xml · nonDerivative · entry 1

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,256

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:48 UTC GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001853794-25-000005 · form4-10242025_081057.xml · derivative · entry 2

Bozilenko Marina · CIK 0001853794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:48 UTC GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001853794-25-000005 · form4-10242025_081057.xml · nonDerivative · entry 1

Bozilenko Marina · CIK 0001853794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,047

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:50 UTC GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001190418-25-000005 · form4-10242025_081032.xml · derivative · entry 2

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:50 UTC GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001190418-25-000005 · form4-10242025_081032.xml · nonDerivative · entry 1

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,859

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:49 UTC
WAN MARK ADirector
GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001190472-25-000005 · form4-10242025_081015.xml · derivative · entry 2

WAN MARK A · CIK 0001190472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:49 UTC
WAN MARK ADirector
GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001190472-25-000005 · form4-10242025_081015.xml · nonDerivative · entry 1

WAN MARK A · CIK 0001190472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,859

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:45 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001248144-25-000004 · form4-10242025_081019.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:45 UTC
ADAMS ADRIANDirector
GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001248144-25-000004 · form4-10242025_081019.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,609

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:41 UTC
JAIN ABHINAVDirector
GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001981291-25-000006 · form4-10242025_081013.xml · derivative · entry 2

JAIN ABHINAV · CIK 0001981291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:41 UTC
JAIN ABHINAVDirector
GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001981291-25-000006 · form4-10242025_081013.xml · nonDerivative · entry 1

JAIN ABHINAV · CIK 0001981291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,312

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:46 UTC GrantStock Option (Right to Buy) · Derivative 25,600 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001305178-25-000004 · form4-10242025_081048.xml · derivative · entry 2

Broadfoot Jill Marie · CIK 0001305178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2035-10-22

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 20:46 UTC GrantCommon Stock 4,267 $0.00 $0.00
Disclosure

SEC source: 0001305178-25-000004 · form4-10242025_081048.xml · nonDerivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,547

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Read SEC document
October 15, 2025 Filed Oct 16, 2025 22:49 UTC GrantDirector Stock Option (right to buy) · Derivative 38,381 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001774807-25-000005 · form4-10162025_101009.xml · derivative · entry 2

Todisco Joseph · CIK 0001774807 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,381

Underlying: Common Stock · 38,381 shares

Expires 2035-10-14

F3 · derivative.exercise_date: The shares subject to the option shall vest in three equal consecutive annual installments on October 14, 2026, October 14, 2027, and October 14, 2028, subject to the Reporting Person's continuous service to the Company.

Read SEC document
October 15, 2025 Filed Oct 16, 2025 22:49 UTC GrantCommon Stock 6,397 $0.00 $0.00
Disclosure

SEC source: 0001774807-25-000005 · form4-10162025_101009.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,397

F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on October 14, 2026, October 14, 2027, and October 14, 2028.

Read SEC document
May 20, 2025 Filed May 21, 2025 22:57 UTC
Aslam ShakilChief Medical Officer
Tax withholdingCommom Stock 4,517 $0.52 $2,328.51
Disclosure

SEC source: 0001415889-25-013995 · form4-05212025_100513.xml · nonDerivative · entry 1

Aslam Shakil · CIK 0002040805 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,178

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.